Distinct domains of the RelA NF-kappaB subunit are required for negative cross-talk and direct interaction with the glucocorticoid receptor.
about
Receptor interacting protein RIP140 inhibits both positive and negative gene regulation by glucocorticoidsThe glucocorticoid receptor inhibits NFkappaB by interfering with serine-2 phosphorylation of the RNA polymerase II carboxy-terminal domainThe RelA NF-kappaB subunit and the aryl hydrocarbon receptor (AhR) cooperate to transactivate the c-myc promoter in mammary cellsIdentification of glucocorticoid receptor domains involved in transrepression of transforming growth factor-beta actionNF-κB repression by PIAS3 mediated RelA SUMOylationCytosolic glucocorticoid receptor interaction with nuclear factor-kappa B proteins in rat liver cellsA pilot study on the combination treatment of reduced-fluence photodynamic therapy, intravitreal ranibizumab, intravitreal dexamethasone and oral minocycline for neovascular age-related macular degeneration.Distinct glucocorticoid receptor transcriptional regulatory surfaces mediate the cytotoxic and cytostatic effects of glucocorticoidsCross-talk between glucocorticoid receptor and AP-1.NCX-1015, a nitric-oxide derivative of prednisolone, enhances regulatory T cells in the lamina propria and protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis in mice.Growing old with nuclear factor-kappaBVBP15, a novel anti-inflammatory and membrane-stabilizer, improves muscular dystrophy without side effects.Cytoplasmic catalytic subunit of protein kinase A mediates cross-repression by NF-kappa B and the glucocorticoid receptor.Role of the progesterone receptor (PR) in the regulation of inflammatory response pathways and aromatase in the breast.Elucidating the identity of resistance mechanisms to prednisolone exposure in acute lymphoblastic leukemia cells through transcriptomic analysis: A computational approach.Nuclear receptors in inflammation control: repression by GR and beyond.Nuclear factor-κB: a key regulator in health and disease of lungs.SHP limits TLR signaling, an inducible transcriptional corepressorNegative cross-talk between the human orphan nuclear receptor Nur77/NAK-1/TR3 and nuclear factor-kappaB.Chromatin-dependent E1A activity modulates NF-kappaB RelA-mediated repression of glucocorticoid receptor-dependent transcription.The p38 MAP kinase inhibitor SB203580 enhances nuclear factor-kappa B transcriptional activity by a non-specific effect upon the ERK pathway.Among translational effectors, p70S6k is uniquely sensitive to inhibition by glucocorticoids.Various glucocorticoids differ in their ability to induce gene expression, apoptosis and to repress NF-kappaB-dependent transcription.Glucocorticoid inhibition of SP-A gene expression in lung type II cells is mediated via the TTF-1-binding element.Tumour necrosis factor alpha and nuclear factor kappaB inhibit transcription of human TFF3 encoding a gastrointestinal healing peptide.Identification of overlapping AP-2/NF-kappa B-responsive elements on the rat cholecystokinin gene promoter.Inhibition of NF-kappa B binding correlates with increased nuclear glucocorticoid receptor levels in acute alcohol-treated human monocytes.Activation of nuclear factor kappaB by nitric oxide in rat striatal neurones: differential inhibition of the p50 and p65 subunits by dexamethasone.
P2860
Q22009969-51277DB7-BCA4-4262-87E4-2A09625788A9Q24600925-560364F9-CD6A-4F05-A93F-D2EFFA61976CQ28140206-65E9120F-7615-44AB-A733-7BD32B879CDEQ28155857-CB2ED98D-6965-4A51-9FF2-539C267B7C61Q28483894-F4657F64-AF61-47C1-9DD6-0D4DF944AEEFQ28571233-B12134B6-C2B9-4825-A05D-5BF36A792BEAQ33811616-EE4B42B1-C762-471C-8245-F3B7E4EFE13BQ33958788-78BE2AB5-6450-45C9-B807-4362A7B98F7EQ34279367-8E3F0DB8-4455-4A6E-A1D0-5C7FAB2D4B5DQ34389791-3E0AC95D-6837-45EE-96B5-C0247DE84675Q34966171-1C12763D-F208-41F2-BF43-5DF1A8EC7351Q34981147-C324B4F8-D022-4264-9D75-1CB47DE18E8FQ35344249-C31DDD1C-B06C-4612-853C-83CDE6131273Q35839056-E03C4FE6-3339-47EE-B7DF-39ECA2AA134CQ35856573-93599DB7-064A-4A70-AB19-EFCD44C3CDE9Q37209671-B453431B-192A-4E0B-9362-310427A17C3AQ37904904-E4A10F6A-DBE1-4378-885B-32BF19157642Q39333642-5CD086C0-BC34-4315-8034-2392DAF8A4EAQ40157081-9C6853C2-FA9C-4AB9-B8BE-02D1CED55911Q40489501-076C9CD6-EB9B-4B9E-8007-C1832ACC0372Q40858871-373E45A4-CCE2-4495-B0F0-9A30FAC4C3EFQ40889077-D2E05BE3-9252-48CD-B816-FD1D11CA6289Q40979915-F999E17E-B04C-4407-9362-81246454F8D5Q42453184-E2C82AAD-26C9-411D-830A-71C8CAFFDE85Q43005466-3D4DC094-3167-4624-AF25-035A87C3734DQ43507998-597A0A0E-DE66-4E1D-B4D6-8E344EF80A79Q44261118-753FE954-E03F-42CE-AC83-D45A7A83F89BQ48174963-86707171-4CA9-4C9A-9FAA-7BD85BE87C2F
P2860
Distinct domains of the RelA NF-kappaB subunit are required for negative cross-talk and direct interaction with the glucocorticoid receptor.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh-hant
name
Distinct domains of the RelA N ...... h the glucocorticoid receptor.
@en
Distinct domains of the RelA N ...... h the glucocorticoid receptor.
@nl
type
label
Distinct domains of the RelA N ...... h the glucocorticoid receptor.
@en
Distinct domains of the RelA N ...... h the glucocorticoid receptor.
@nl
prefLabel
Distinct domains of the RelA N ...... h the glucocorticoid receptor.
@en
Distinct domains of the RelA N ...... h the glucocorticoid receptor.
@nl
P2093
P2860
P356
P1476
Distinct domains of the RelA N ...... h the glucocorticoid receptor.
@en
P2093
Baeuerle PA
Kalkhoven E
Schmitz ML
van Heerde EC
van der Burg B
van der Saag PT
P2860
P304
22278-22284
P356
10.1074/JBC.272.35.22278
P407
P577
1997-08-01T00:00:00Z